# Histogen Inc.

Histogen Inc. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** Histogen Inc.
- **Former names in filing history:** Conatus Pharmaceuticals Inc. (2014-08-13 to 2020-05-21); Conatus Pharmaceuticals Inc (2006-11-30 to 2014-06-23)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001383701

## About

Histogen Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001383701, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-09, it reported annual revenue of USD 3,769,000; total assets of USD 19,073,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $3.8M (USD 3,769,000)
- **Total assets:** $19.1M (USD 19,073,000)
- **Cash and equivalents:** $12.1M (USD 12,109,000)
- **Operating cash flow:** -$9.7M (USD -9,683,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.0M (USD 1,032,000)
- **Total assets:** $27.2M (USD 27,245,000)
- **Cash and equivalents:** $18.7M (USD 18,685,000)
- **Operating cash flow:** -$14.5M (USD -14,532,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $2.1M (USD 2,059,000)
- **Total assets:** $15.0M (USD 15,013,000)
- **Cash and equivalents:** $6.8M (USD 6,763,000)
- **Operating cash flow:** -$12.1M (USD -12,054,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $21.7M (USD 21,717,000)
- **Net income:** -$11.4M (USD -11,385,000)
- **Total assets:** $21.8M (USD 21,827,000)
- **Cash and equivalents:** $20.7M (USD 20,703,000)
- **Operating cash flow:** -$20.2M (USD -20,202,000)
- **Later filings:** Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2023-12-14 — period 2023-12-14 — 8-K
- Form 8-K — filed 2023-12-05 — period 2023-12-05 — 8-K
- Form 10-Q — filed 2023-11-09 — period 2023-09-30 — 10-Q
- Form DEF 14A — filed 2023-10-18 — period 2023-12-05 — DEF 14A
- Form 8-K — filed 2023-10-03 — period 2023-10-03 — 8-K
- Form 8-K — filed 2023-09-26 — period 2023-09-26 — 8-K
- Form 8-K — filed 2023-09-18 — period 2023-09-12 — 8-K
- Form 8-K — filed 2023-08-15 — period 2023-08-11 — 8-K
- Form 10-Q — filed 2023-08-10 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-07-05 — period 2023-07-05 — 8-K
- Form 8-K — filed 2023-06-21 — period 2023-06-20 — 8-K
- Form 8-K — filed 2023-06-05 — period 2023-06-05 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/histogen-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology